My son has an IgG and IgA deficiency with two weekly infusions of immunoglobulin via a Portocath. Up until recently he had his treatment on the paediatric ward in a single room which we were told was to reduce the chance of infection. He has now moved to adult services and is now having the treatment in the ambulatory ward. Is this safe?
Most patients with a PID who infuse in hospitals do so in open bays on a ward safely. Please do discuss your concerns with your immunology team. You may also want to explore alternative ways of having immunoglobulin therapy, such as subcutaneous delivery, as this could potentially lead to home therapy options.
Share This Story, Choose Your Platform!